• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Ch. 7 Drug web notes
Ch. 7 Drug web notes

... may be found at a scene. The reference book gives a picture of the drug and states whether it is prescription, over-the-counter, or a controlled substance; it gives more detailed information about the drug as well. ...
Ch 7 Drug Webnotes ppt
Ch 7 Drug Webnotes ppt

... may be found at a scene. The reference book gives a picture of the drug and states whether it is prescription, over-the-counter, or a controlled substance; it gives more detailed information about the drug as well. ...
A. Introduction to drug discovery
A. Introduction to drug discovery

... Studying the drug-target interaction. The pharmacokinetic profile of drugs ...
Law20060112 - Dr Ted Williams
Law20060112 - Dr Ted Williams

... Manufacturer or FDA can initiate Insurance company can initiate (e.g. Prilosec) OTC Drug Review Process primary mechanism by which drugs are switched • There is a committee at FDA which advises on Rx to OTC switches • Rx examples switched to OTC: Benadryl, ...
Drug dosage - jan.ucc.nau.edu
Drug dosage - jan.ucc.nau.edu

... Age as a factor that influences the drug response curve • Infants take longer to metabolize most drugs because of an immature liver • Older adults also do not metabolize drugs quickly because their system less efficient ...
Form O IND
Form O IND

... Immediately life-threatening disease or condition means a stage of disease in which there is reasonable likelihood that death will occur within a matter of months or in which premature death is likely without early treatment. Serious disease or condition means a disease or condition associated with ...
FOR IMMEDIATE RELEASE CONTACTS DIPHARMA: +41(0
FOR IMMEDIATE RELEASE CONTACTS DIPHARMA: +41(0

... tablet formulations of Carglumic acid, together with the proprietary technology developed to improve the product stability, without modifying the pharmaceutical form the patients are familiar to. Carglumic acid formulation is the fourth Dipharma product approaching the market: Diterin® (sapropterin ...
LOs Parmicokinetics 5 - 8 - PBL-J-2015
LOs Parmicokinetics 5 - 8 - PBL-J-2015

... Body Burden = total amount of compound in body (Q) = Cp x Vd (from the above equation) Eg: Digoxin has a volume of distribution of 7L/kg. What is the peak plasma concentration if 500µg is administered to a 12kg child. ...
A Healthy Prognosis For Some Stocks: Drugs and Robots
A Healthy Prognosis For Some Stocks: Drugs and Robots

... to manufacture than generic pharmaceuticals — a manufacturing plant and equipment costs perhaps $100 million — and the clinical trials can be more complicated. Our biosimilar play is South Korea’s Celltrion [068270.Korea], one of a few pure-play biosimilar companies. The stock has had a good run, an ...
Moisture Transfer between Formulation Components in a
Moisture Transfer between Formulation Components in a

...  Leverage our comprehensive expertise in drug delivery – develop collaborations with pharmaceutical companies  Work with the different administrative units to expedite legal and contractual issues  Serve as a platform for training grants and program project grants that are focused on drug deliver ...
medicinal-chemistry-lect-1-n-15-drug-design
medicinal-chemistry-lect-1-n-15-drug-design

... concerned with the design, development and synthesis of pharmaceutical drugs. ...
gtbtn07USA229
gtbtn07USA229

... its over-the-counter (OTC) labelling regulations and the tentative final monograph (TFM) for OTC internal analgesic, antipyretic, and anti-rheumatic (IAAA) drug products to include new warnings and other labelling requirements advising consumers about potential risks and when to consult a doctor. FD ...
McCainMay99resp - Lupron Victims Hub
McCainMay99resp - Lupron Victims Hub

... products contain risks as well as benefits and it is often impossible to predict which individuals may have increased sensitivity to particular drugs. After thorough review of all the required data prior to marketing, FDA’s decision to market a new drug is based on the answers to two questions: (1) ...
Rational prescribing in the older adult
Rational prescribing in the older adult

... ADRs 2-3x higher in elderly cf young – Cusak et al, 1997 ...
Introduction To Pharmacology
Introduction To Pharmacology

... for the fit of the drug to its receptor. • Between a quarter and a half of all drugs in use exist as stereoisomers. In most cases the stereoisomers are chiral enantiomers. Enantiomers are mirrored image twin molecules that result from the presence of an asymmetric carbon, or in a few cases, other as ...
NUR 312: Pharmacology in Nursing II
NUR 312: Pharmacology in Nursing II

... Hold MAOI's, do not lie down (increases BP in head) Thorazine 100 mg. 1M repeat if necessary (blocks norepinepherine) Phentolamine IV in 5 mg dose (binds with. norepinepherine) Cooling blanket. Seratonin Syndrome: Occurs when SSRI’s are administered too close to D/C of MAOl's Confusion, disorientati ...
Drugs and the Law
Drugs and the Law

... pay a tax and failure to comply meant a large fine or prison term for tax evasion. ...
Route of Adminstration
Route of Adminstration

... • Weak acids: excreted faster in alkaline pH (anion form favored) • Weak bases: excreted faster in acidic pH (cation form favored) ...
2017_GA2_1_1
2017_GA2_1_1

... methods to maintain daily sustenance other than by cultivating opium or other drugs that are extremely appealing due to the rate at which they can be produced and their high-income potential, Affirming the significant role border control and cooperation between neighboring countries will play in ens ...
Mar. 06, 2008 | Heath Ledger stopped breathing. An
Mar. 06, 2008 | Heath Ledger stopped breathing. An

... can be addictive. The warning may even advise you to talk to your doctor about other medications. However, no notation is made that with prolonged use, the pills tend to be less effective so that you will want to increase the dose. For the average person, without knowledge of pharmacology, the risk ...
The Use and Abuse of Psychoactive Drugs
The Use and Abuse of Psychoactive Drugs

... Use of medication without a prescription in a way other than as prescribed, or for the experience or feelings elicited. Prescription drugs are abused at a rate behind only marijuana and alcohol. Both prescription and OTC medications can be harmful, even fatal, if used improperly. – Taking the incorr ...
Chapter 2 Law and Ethics of Pharmacy Teresa Hopper
Chapter 2 Law and Ethics of Pharmacy Teresa Hopper

... • Monographs or package inserts list pertinent information • Most reference books list trade and generic names of drugs, indications, classifications, ...
Functional Contextual Pharmacology #4
Functional Contextual Pharmacology #4

... viable alternative – one with more scientific support ? Potential, in the absence of any clear empirical guidance, of analysing behavioral drugs in language of core hexaflex ...
Cystic fibrosis in an era of genomically guided therapy
Cystic fibrosis in an era of genomically guided therapy

... In opposition to the falloff in approval of drugs for common conditions by the FDA, there has been an acceleration in the rate of orphan drug approvals. 2008 was a record year, with the FDA’s Office of Orphan Drug Development designating 165 products for orphan diseases. As of May 2009, the FDA had ...
Designer Drugs
Designer Drugs

... Methoxetamine, MXE, Mexxy, Roflcopter)—Synthetic dissociative psychedelics like PCP and ketamine. FAAH Inhibitors– enzyme is responsible for regulating brain ...
< 1 ... 138 139 140 141 142 143 144 145 146 ... 161 >

Orphan drug

An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease.In the US and EU it is easier to gain marketing approval for an orphan drug, and there may be other financial incentives, such as extended exclusivity periods, all intended to encourage the development of drugs which might otherwise lack a sufficient profit motive. The assignment of orphan status to a disease and to any drugs developed to treat it is a matter of public policy in many countries, and has resulted in medical breakthroughs that may not have otherwise been achieved due to the economics of drug research and development.According to Thomson Reuters in their 2012 publication ""The Economic Power of Orphan Drugs"", there has been increased investing in orphan drug Research and Development partly due to the U. S. Orphan Drug Act (ODA) 1983 and similar Acts in other regions of the world and also driven by ""high-profile philanthropic funding."" The period between 2001 to 2011 was the ""most productive period in the history of orphan drug development, in terms of average annual orphan drug designations and orphan drug approvals."" For the same decade the compound annual growth rate (CAGR) of the orphan drugs was an ""impressive 25.8 percent, compared to only 20.1 percent for a matched control group of non-orphan drugs."" By 2012 the market for orphan drugs was worth USD$637 million compared to the USD$638 million matched control group of non-orphan drugs, Thomson Reuters.By 2012, ""the revenue-generating potential of orphan drugs [was] as great as for non-orphan drugs, even though patient populations for rare diseases are significantly smaller. Moreover, we suggest that orphan drugs have greater profitability when considered in the full context of developmental drivers including government financial incentives, smaller clinical trial sizes, shorter clinical trial times and higher rates of regulatory success.""
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report